← Back to Search

HPV Education Interventions for Health Personnel Attitudes

N/A

Recruiting

Led By Eva M Moya, PhD, LMSW

Research Sponsored by University of Texas, El Paso

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Declines or is unable to participate in the full intervention and follow-up time-points

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two interventions to see which is more effective at reducing HPV vaccine hesitancy and increasing uptake and completion among people living in the El Paso U.S.-Mexico Border Region.

Who is the study for?

This trial is for current or future healthcare providers who can prescribe/administer the HPV vaccine and are based in the El Paso U.S.-Mexico Border Region. They must be able to participate fully and follow up in English. Those already part of earlier phases of this research or not affiliated with the specified region cannot join.

What is being tested?

The study tests two types of interventions on healthcare providers: a tailored education program about HPV and professional skills training versus general HPV education. The goal is to see if these methods improve their knowledge, attitudes, and communication strategies regarding HPV vaccination.

What are the potential side effects?

Since this trial focuses on educational interventions rather than medical treatments, there are no direct physical side effects expected from participating. However, participants may experience changes in attitude or increased workload due to intervention activities.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot or do not want to commit to the full study duration and activities.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Between-group changes in proportions from post-intervention scores of the Healthcare Provider (HCP) Practices scale on the Healthcare Personnel Survey

Secondary study objectives

Between-group changes in proportions from post-intervention scores of the Human Papillomavirus (HPV) Vaccine Attitudes scale on the Healthcare Personnel Survey

Between-group changes in proportions from post-intervention scores on the Human Papillomavirus (HPV) Knowledge scale on the Healthcare Personnel Survey